These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 14416562)

  • 1. The hormone treatment of advanced breast cancer: comparative therapy with testosterone and two experimental androgens.
    LEWISON EF; GROW JL; TRIMBLE FH
    Am Surg; 1960 Apr; 26():278-83. PubMed ID: 14416562
    [No Abstract]   [Full Text] [Related]  

  • 2. Hormonal therapy in cancer of the breast. XIV. The effect of 19-nortestosterone propionate therapy on clinical course and hormonal excretion.
    SEGALOFF A; BOWERS CY; RONGONE EL; MURISON PJ
    Cancer; 1959; 12(4):735-7. PubMed ID: 13663017
    [No Abstract]   [Full Text] [Related]  

  • 3. [Preliminary results with the use of non-androgenic derivatives of testosterone in the treatment of advanced breast cancer. Preliminary note].
    MAINOLDI F; MONETTI C; GALLETTI F
    Radiobiol Radioter Fis Med; 1961 May; 16():99-109. PubMed ID: 13765471
    [No Abstract]   [Full Text] [Related]  

  • 4. Testosterone in far advanced breast cancer; preliminary report.
    DAVISON TC; LETTON AH
    South Surg; 1948 Mar; 14(3):170-84. PubMed ID: 18907494
    [No Abstract]   [Full Text] [Related]  

  • 5. Testosterone in the treatment of advanced breast cancer; a preliminary report.
    JONES HW
    South Med J; 1948 Jan; 41(1):4-11. PubMed ID: 18903103
    [No Abstract]   [Full Text] [Related]  

  • 6. Androgens in advanced cancer of the breast.
    DeCOURCY JL
    Cinci J Med; 1948 Oct; 29(10):556-9. PubMed ID: 18884818
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of advanced mammary cancer with testosterone.
    CUTLER M; SCHLEMENSON M
    J Am Med Assoc; 1948 Sep; 138(3):187-90. PubMed ID: 18877485
    [No Abstract]   [Full Text] [Related]  

  • 8. Use of 2alpha-methyldihydrotestosterone propionate in treatment of advanced cancer of the breast: a group report.
    BLACKBURN CM
    Cancer Chemother Rep; 1962 Feb; 16():279-82. PubMed ID: 13869675
    [No Abstract]   [Full Text] [Related]  

  • 9. COMBINED ESTROGENIC AND ANDROGENIC HORMONE THERAPY IN ADVANCED BREAST CANCER.
    KENNEDY BJ; BROWN JH
    Cancer; 1965 Apr; 18():431-5. PubMed ID: 14278039
    [No Abstract]   [Full Text] [Related]  

  • 10. Antitumor efficacy of 2alpha-methyl dihydrotestosterone propionate in advanced breast cancer.
    THOMAS AN; GORDAN GS; GOLDMANL ; LOWE R
    Cancer; 1962; 15():176-8. PubMed ID: 13920749
    [No Abstract]   [Full Text] [Related]  

  • 11. [Radiological aspects and course of metastatic bone lesions due to breast neoplasms in patients treated with an enolic derivative of testosterone without androgenic activity].
    MAINOLDI F; BERNARDI L
    Radiol Med; 1961 Jun; 47():530-41. PubMed ID: 13765470
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of a breast cancer patient with Endoxan and an anabolic hormone. Empirical report].
    KILL JM
    Munch Med Wochenschr; 1961 Sep; 103():1767-8. PubMed ID: 13755948
    [No Abstract]   [Full Text] [Related]  

  • 13. [The hormonal treatment of metastases of cancer of the breast].
    MASSE L
    J Med Bord; 1962 Apr; 139():489-91. PubMed ID: 14470904
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of carcinoma of the breast with testosterone therapy.
    TOONE WM
    Bull Vanc Med Assoc; 1948 Jan; 24(4):118. PubMed ID: 18914506
    [No Abstract]   [Full Text] [Related]  

  • 15. A comparative evaluation of adrenalectomy and androgen in advanced mammary carcinoma.
    DAO TL; TAN E
    Cancer Chemother Rep; 1962 Feb; 16():309-15. PubMed ID: 13883500
    [No Abstract]   [Full Text] [Related]  

  • 16. Testosterone propionate in the treatment of advanced carcinoma of the breast.
    WATSON JR; FETTERMAN GH
    Surg Gynecol Obstet; 1949 Jun; 88(6):702-10. PubMed ID: 18130310
    [No Abstract]   [Full Text] [Related]  

  • 17. [The use of enolic derivatives of testosterone, in combination with radiotherapy, in patients with metastasizing neoplasms of the breast and of the genital area].
    SIGHINOLFI R
    Policlinico Prat; 1962 Apr; 69():532-40. PubMed ID: 14039271
    [No Abstract]   [Full Text] [Related]  

  • 18. Postmenopausal serum androgens, oestrogens and breast cancer risk: the European prospective investigation into cancer and nutrition.
    Kaaks R; Rinaldi S; Key TJ; Berrino F; Peeters PH; Biessy C; Dossus L; Lukanova A; Bingham S; Khaw KT; Allen NE; Bueno-de-Mesquita HB; van Gils CH; Grobbee D; Boeing H; Lahmann PH; Nagel G; Chang-Claude J; Clavel-Chapelon F; Fournier A; Thiébaut A; González CA; Quirós JR; Tormo MJ; Ardanaz E; Amiano P; Krogh V; Palli D; Panico S; Tumino R; Vineis P; Trichopoulou A; Kalapothaki V; Trichopoulos D; Ferrari P; Norat T; Saracci R; Riboli E
    Endocr Relat Cancer; 2005 Dec; 12(4):1071-82. PubMed ID: 16322344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of androstan-3, 11, dione-17beta-hydroxy, 17-methyl (compound NSC 19605) in the treatment of advanced breast cancer.
    ANSFIELD FJ; OLSON KB; RASCH O
    Cancer; 1962; 15():330-3. PubMed ID: 13861731
    [No Abstract]   [Full Text] [Related]  

  • 20. [The n-octylenolic ether of dihydrotestosterone associated with x-ray therapy in the treatment of advanced breast carcinoma].
    MAINOLDI F; MONETTI C
    Radiobiol Radioter Fis Med; 1961 Dec; 16():415-26. PubMed ID: 14468532
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.